Other information
−Removed: Amendment, dated February 21, 2023, to the Employment Agreement, dated as of December 18, 2018, as extended effective October 15, 2021, by and between TherapeuticsMD, Inc.
−Removed: and Marlan Walker (1)
−Removed: General Consulting and Services Agreement by and between TherapeuticsMD, Inc.
−Removed: and MCD Consulting Management Services, LLC, dated February 21, 2023 (1)
+Added: Composite Amended and Restated Articles of Incorporation, as amended.
+Added: Fourth Amendment to Bylaws of the Company, dated June 29, 2023.
+Added: Subscription Agreement, dated May 1, 2023, between TherapeuticsMD, Inc.
+Added: and Rubric Capital Management LP.
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a)
6 unchanged sentences
Furnished herewith.
−Removed: Filed as an exhibit to Form 8-K filed with the Commission on February 27, 2023 and incorporated herein by reference (SEC File No.
+Added: Filed as Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the Commission on July 6, 2023 and incorporated herein by reference (SEC File No.
+Added: Filed as Appendix B to the Company’s Definitive Proxy Statement on Schedule 14A, filed with the Commission on May 17, 2023 and incorporated herein by reference (SEC File No.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
+Added: August 14, 2023
TherapeuticsMD, Inc.
5 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.